IL108444A0 - C2 taxane derivatives and pharmaceutical compositions containing them - Google Patents
C2 taxane derivatives and pharmaceutical compositions containing themInfo
- Publication number
- IL108444A0 IL108444A0 IL10844494A IL10844494A IL108444A0 IL 108444 A0 IL108444 A0 IL 108444A0 IL 10844494 A IL10844494 A IL 10844494A IL 10844494 A IL10844494 A IL 10844494A IL 108444 A0 IL108444 A0 IL 108444A0
- Authority
- IL
- Israel
- Prior art keywords
- pharmaceutical compositions
- taxane derivatives
- compositions containing
- substituent
- taxane
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
- C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
- C07D407/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D305/00—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms
- C07D305/14—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms condensed with carbocyclic rings or ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
- C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
- C07D493/08—Bridged systems
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Hematology (AREA)
- Oncology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Epoxy Compounds (AREA)
- Peptides Or Proteins (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US08/010,798 US5399726A (en) | 1993-01-29 | 1993-01-29 | Process for the preparation of baccatin III analogs bearing new C2 and C4 functional groups |
| US3485293A | 1993-03-22 | 1993-03-22 | |
| US9471593A | 1993-07-20 | 1993-07-20 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL108444A0 true IL108444A0 (en) | 1994-04-12 |
Family
ID=27359309
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL10844494A IL108444A0 (en) | 1993-01-29 | 1994-01-26 | C2 taxane derivatives and pharmaceutical compositions containing them |
Country Status (13)
| Country | Link |
|---|---|
| EP (2) | EP0681573B1 (es) |
| JP (2) | JP3452928B2 (es) |
| CN (1) | CN1125061C (es) |
| AT (2) | ATE220064T1 (es) |
| AU (2) | AU685778B2 (es) |
| CA (2) | CA2155013C (es) |
| DE (2) | DE69430902T2 (es) |
| DK (1) | DK0681573T3 (es) |
| ES (1) | ES2176237T3 (es) |
| IL (1) | IL108444A0 (es) |
| PT (1) | PT681573E (es) |
| TW (2) | TW360646B (es) |
| WO (2) | WO1994017052A1 (es) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5710287A (en) | 1991-09-23 | 1998-01-20 | Florida State University | Taxanes having an amino substituted side-chain and pharmaceutical compositions containing them |
| IL108443A0 (en) * | 1993-01-29 | 1994-04-12 | Univ Florida State | C7 taxane derivatives and pharmaceutical compositions containing them |
| FR2702212B1 (fr) * | 1993-03-02 | 1995-04-07 | Rhone Poulenc Rorer Sa | Nouveaux taxoïdes, leur préparation et les compositions pharmaceutiques qui les contiennent. |
| US5677470A (en) * | 1994-06-28 | 1997-10-14 | Tanabe Seiyaku Co., Ltd. | Baccatin derivatives and processes for preparing the same |
| FR2723094A1 (fr) * | 1994-07-26 | 1996-02-02 | Rhone Poulenc Rorer Sa | Nouveaux taxoides, leur preparation et les compositions pharmaceutiques qui les contiennent |
| CA2162759A1 (en) * | 1994-11-17 | 1996-05-18 | Kenji Tsujihara | Baccatin derivatives and processes for preparing the same |
| EP0868422A1 (de) * | 1996-09-24 | 1998-10-07 | Marigen S.A. | Ultramikroemulsionen aus spontan dispergierbaren konzentraten mit antitumoral und antiviral wirksamen estern von baccatin-iii-verbindungen |
| HUP0101457A3 (en) * | 1997-12-31 | 2003-01-28 | Bristol Myers Squibb Co | Antitumor 2-aroyl-4-acyl paclitaxel analogs and medicaments containing them , their intermediates and method for producing them |
| ITMI20021921A1 (it) * | 2002-09-10 | 2004-03-11 | Indena Spa | Funzionalizzazione della posizione 14 dei nuclei tassanici e sintesi di nuovi derivati antitumorali. |
| BRPI0511109A (pt) * | 2004-05-14 | 2007-11-27 | Immunogen Inc | método fácil para sintetizar compostos de baccatin iii |
| US20130090484A1 (en) * | 2011-10-11 | 2013-04-11 | Scinopharm Taiwan Ltd. | Process for making an intermediate of cabazitaxel |
| CN104250235B (zh) * | 2014-09-24 | 2016-10-05 | 江苏红豆杉药业有限公司 | 一种紫杉醇的制备方法 |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4942184A (en) * | 1988-03-07 | 1990-07-17 | The United States Of America As Represented By The Department Of Health And Human Services | Water soluble, antineoplastic derivatives of taxol |
-
1994
- 1994-01-26 IL IL10844494A patent/IL108444A0/xx unknown
- 1994-01-28 WO PCT/US1994/001223 patent/WO1994017052A1/en active IP Right Grant
- 1994-01-28 DK DK94907959T patent/DK0681573T3/da active
- 1994-01-28 CA CA002155013A patent/CA2155013C/en not_active Expired - Fee Related
- 1994-01-28 ES ES94907959T patent/ES2176237T3/es not_active Expired - Lifetime
- 1994-01-28 EP EP94907959A patent/EP0681573B1/en not_active Expired - Lifetime
- 1994-01-28 PT PT94907959T patent/PT681573E/pt unknown
- 1994-01-28 AU AU61327/94A patent/AU685778B2/en not_active Ceased
- 1994-01-28 AT AT94907959T patent/ATE220064T1/de not_active IP Right Cessation
- 1994-01-28 DE DE69430902T patent/DE69430902T2/de not_active Expired - Fee Related
- 1994-01-28 JP JP51740094A patent/JP3452928B2/ja not_active Expired - Fee Related
- 1994-01-29 CN CN94101158A patent/CN1125061C/zh not_active Expired - Fee Related
- 1994-01-31 JP JP51738694A patent/JP3741715B2/ja not_active Expired - Fee Related
- 1994-01-31 CA CA002155014A patent/CA2155014C/en not_active Expired - Fee Related
- 1994-01-31 AT AT94909517T patent/ATE217870T1/de not_active IP Right Cessation
- 1994-01-31 AU AU62340/94A patent/AU684268B2/en not_active Ceased
- 1994-01-31 EP EP94909517A patent/EP0681575B1/en not_active Expired - Lifetime
- 1994-01-31 DE DE69430661T patent/DE69430661T2/de not_active Expired - Fee Related
- 1994-01-31 WO PCT/US1994/001099 patent/WO1994017051A1/en active IP Right Grant
- 1994-04-18 TW TW083103421A patent/TW360646B/zh not_active IP Right Cessation
- 1994-05-12 TW TW083104292A patent/TW402598B/zh not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| CA2155014C (en) | 2007-06-26 |
| JPH10502327A (ja) | 1998-03-03 |
| CA2155013A1 (en) | 1994-08-04 |
| CN1125061C (zh) | 2003-10-22 |
| CN1101346A (zh) | 1995-04-12 |
| TW402598B (en) | 2000-08-21 |
| JPH08506326A (ja) | 1996-07-09 |
| AU685778B2 (en) | 1998-01-29 |
| EP0681573A1 (en) | 1995-11-15 |
| CA2155014A1 (en) | 1994-08-04 |
| DE69430902T2 (de) | 2002-10-24 |
| DE69430661D1 (de) | 2002-06-27 |
| JP3452928B2 (ja) | 2003-10-06 |
| AU684268B2 (en) | 1997-12-11 |
| WO1994017052A1 (en) | 1994-08-04 |
| EP0681575A4 (es) | 1995-12-13 |
| EP0681573B1 (en) | 2002-07-03 |
| EP0681573A4 (es) | 1995-12-06 |
| AU6132794A (en) | 1994-08-15 |
| DK0681573T3 (da) | 2002-10-28 |
| DE69430661T2 (de) | 2002-10-24 |
| DE69430902D1 (de) | 2002-08-08 |
| TW360646B (en) | 1999-06-11 |
| ATE220064T1 (de) | 2002-07-15 |
| PT681573E (pt) | 2002-11-29 |
| EP0681575A1 (en) | 1995-11-15 |
| EP0681575B1 (en) | 2002-05-22 |
| AU6234094A (en) | 1994-08-15 |
| WO1994017051A1 (en) | 1994-08-04 |
| ATE217870T1 (de) | 2002-06-15 |
| CA2155013C (en) | 2006-04-11 |
| ES2176237T3 (es) | 2002-12-01 |
| JP3741715B2 (ja) | 2006-02-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NL350077I2 (nl) | Cyprosulfamide | |
| TR199800825T2 (xx) | Farnesil protein transferini inhibe eden (imidazol-5-il) metil-2-kinolinon t�revleri. | |
| FI943749A0 (fi) | Taksaanijohdannaisten fosfono-oksimetyylieetterit | |
| IL110031A0 (en) | Phenyl heterocycles, their manufacture and pharmaceutical compositions containing them | |
| IL116078A (en) | Substituted heterocyclic compounds capable of inhibiting serine proteases and pharmaceutical compositions containing them | |
| YU40997A (sh) | Novi oksadiazoli, postupci za njihovo pripremanje | |
| MY119820A (en) | Guanidine mimics as factor xa inhibitors | |
| MX9601360A (es) | Mezcla estabilizante sinergistica. | |
| FI933568A (fi) | 9-((substituerad glycyl)amido)-6-demetyl-6-deoxitetracykliner | |
| FI914723A0 (fi) | 17b-substituerade 4-aza-5a-androstan -3-jon-derivat och foerfarande foer framstaellning av desamma. | |
| IL108444A0 (en) | C2 taxane derivatives and pharmaceutical compositions containing them | |
| TR199901765T2 (xx) | S�lfomid-metalloproteaz inhibit�rleri | |
| DE69317764D1 (de) | Aminoacetylmercaptoacetylamid derivate mit enkephalinase- und ace-hemmwirkung | |
| NZ334954A (en) | Substituted heterocycles as anti-tumor agents | |
| PT929565E (pt) | Esteres de nitrato de compostos corticoides e suas aplicacoes farmaceuticas | |
| DK0513675T3 (da) | Hidtil ukendt peptidforbindelse samt fremgangsmåde til fremstilling deraf | |
| JPS56156289A (en) | Metal chelate of 1,4-bis(substituted amino)- 5,8-dihydroxyanthraquinone | |
| IL140070A0 (en) | Benzamide derivatives and pharmaceutical compositions containing the same | |
| ES2191029T3 (es) | Derivados de taxano c7 y composiciones farmaceuticas que los contienen. | |
| FI930171A0 (fi) | Piperidinfoereningar, framstaellning och anvaendning av dessa | |
| MY132969A (en) | New n-phenylamide and n-pyridylamide derivatives, method of preparing them and pharmaceutical compositions containing them | |
| FR2707496B1 (fr) | Compositions pharmaceutiques antiradicalaires et/ou antilipoperoxydantes et/ou hépatotropes. | |
| JPS52100439A (en) | Omega-(arysulfonamido)alkylamines | |
| ATE148459T1 (de) | Spiro(cycloalkylbenzen-1,1'-(1',2',3',4'- tetrahydroisoquinoline)> mit neuroprotektiven eigenschaften |